Thanks dgoynich, I look forward to the postive Ann, look more forward to the resulting sp appreciation.
Do hope this does not become Ground Hog day, that is postive Ann but no sp appreciation!
In regards to fund/ entity calling this a sell/ dud, HAS anyone first hand experience of this and the reason they (fund/entity) ACTUALLY gave this advice, if so what has changed their mind (from hold/buy) and why after the restructuring/code red been implemented.
What is the relevance of this : been suggested that this has hobbled the sp of this company, what are the actual facts behind this, if any. Some clarity would be enlightening, we believe (relevant fund/entity) this is a sell because ..... , is there specific data to support this? Can anyone enlighten us?
Not enough to say 'weak hands' have capitulated because of unspecified advice from said entity, it is in the companies/our interest to give actual facts to support this fact/allegations, then let any thinking person make up their own mind regardless of brokers 'advice'.
- Forums
- ASX - By Stock
- AVR
- My thoughts on AHZ
My thoughts on AHZ, page-101
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M |
Open | High | Low | Value | Volume |
$9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 298 | $9.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.85 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 298 | 9.010 |
1 | 1000 | 9.000 |
1 | 200 | 8.700 |
1 | 200 | 8.500 |
2 | 200 | 8.000 |
Price($) | Vol. | No. |
---|---|---|
9.850 | 1000 | 1 |
9.910 | 231 | 2 |
10.000 | 10250 | 2 |
10.200 | 545 | 1 |
10.500 | 10000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online